This study is currently not recruiting participants.

A Clinical Trial of Observation versus Controlled Intermittent Alternate Occlusion (CIAO) Therapy using Amblyz Glasses for Intermittent Exotropia

Study on Eye Condition Treatment

Not Recruiting
3 years - 11 years
All
Phase N/A

Brief description of study.

The purpose of this study is to determine whether Controlled Intermittent Alternate Occlusion therapy associated with Amblyz glasses is effective in treating intermittent exotropia.

Detailed description of study

The purpose of this study is to determine whether Controlled Intermittent Alternate Occlusion therapy associated with Amblyz glasses is effective in treating intermittent exotropia.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Intermittent Exotropia
  • Age: 3 years - 11 years
  • Gender: All

This study investigates the effectiveness of Controlled Intermittent Alternate Occlusion therapy combined with special glasses in treating intermittent exotropia. Intermittent exotropia is a condition where one eye occasionally moves outward. The glasses used in this study are designed to help control this eye movement.

Participants in the study will use these special glasses as part of their treatment. The study aims to see how well the therapy works in managing the eye condition. No specific details about the procedures are provided in the description.

  • Who can participate: The eligibility criteria for this study have not been specified. Please check with the study coordinators for more information.
  • Study details: Participants will wear special glasses designed to control eye movement. The study will assess the effectiveness of this therapy in treating the condition. If a placebo is part of the study, it will be an inactive substance that looks like the investigational medicine/vaccine but does not contain any medicine.
Updated on 19 Feb 2024. Study ID: 1410556306

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team